Completion of the deal is expected in the first half of 2008 and is subject
to various customary conditions as due diligence, necessary consents, including
workers council, board of directors, shareholders and to the extent applicable,
any other applicable approvals.
France Hybrides, a swine genetics company, will become legally part of
Hendrix Genetics s.a.s and will be integrated in its swine genetics division
Groupe Glon will keep the operational running of France Hybrides in France
(swine breeding and artificial insemination) through its network Sanders.
Both parties have started to investigate a strategic long term minority
shareholding by Sofiprotéol (majority shareholder of Groupe Glon) in the capital
of Hendrix Genetics B.V.
France Hybrides, is a privately held
swine genetics company in France and is a leader in developing swine
breeding stock and technical expertise for the pork meat industry. www.france-hybrides.com
Groupe Glon is headquarterd in Saint-Gérand,
Brittany. Its activities are animal nutrition, agricultural supplies, genetics
and animal health, food industry, services and expertise, with 3,700 employees
and revenues (2006) of € 1,235m. www.groupe-glon.com
Sofiprotéol is headquarted in Paris and was
established in 1983, as the financial firm in France's vegetable oil and
plant-proteins sector. It supports the development and use of oilseed and
rotein-rich crops by providing appropriate financial and productive resources.
Hendrix Genetics B.V.
Hendrix Genetics, headquartered in
Boxmeer, the Netherlands, is a multipecies breeding company. Hendrix Genetics
serves the global pork and poultry industry with wholly owned operations and
joint ventures across the world in 23 countries. www.hendrix-genetics.com
the latest pig news, subscribe here